ORIGINAL ARTICLE
Gastric hyperplastic polyps coexisting with early gastric cancers, adenoma and neuroendocrine cell hyperplasia
More details
Hide details
Submission date: 2015-06-01
Acceptance date: 2015-07-05
Publication date: 2016-05-10
Pol J Pathol 2016;67(1):33-38
KEYWORDS
TOPICS
ABSTRACT
Gastric hyperplastic polyps (GHP) constitute up to 93% of all benign epithelial polyps of the stomach. The average probability of malignant transformation in GHP is 0.6-22% in large series. The aim of the study was to present the coexistence of GHP with early gastric cancer (EGC), gastric adenoma (GA), neuroendocrine cell hyperplasia (NH) and well-differentiated neuroendocrine tumour (NET G1). Three cases were studied to reveal clinical data and morphological changes and to assess the relationship between GHP and accompanying gastric neoplastic lesions.
REFERENCES (31)
1.
Goddard AF, Badreldin R, Pritchard DM, et al. The management of gastric polyps. Gut 2010; 59: 1270-1276.
2.
Park do Y, Lauwers GY. Gastric polyps: classification and management. Arch Pathol Lab Med 2008; 132: 633-640.
3.
Jung JT. Gastric polyps and protruding type gastric cancer. Clin Endosc 2013; 46: 243-247.
4.
Cao H, Wang B, Zhang Z, et al. Distribution trends of gastric polyps: An endoscopy database analysis of 24 121 northern Chinese patients. J Gastoenterol Hepatol 2012; 27: 1175-1180.
5.
Gonzalez-Obeso E, Fujita H, Despande V, et al. Gastric hyperplastic polyps: A heterogeneous clinicopathologic group including a distinct subset best categorized as mucosal prolapse polyp. Am J Surg Pathol 2011; 35: 670-677.
6.
Zea-Iriarte WL, Sekine I, Itsuno M, et al. Carcinoma in gastric hyperplastic polyps. A phenotypic study. Dig Dis Sci 1996; 41: 377-386.
7.
Imura J, Hayashi S, Ichikawa K, et al. Malignant transformation of hyperplastic gastric polyps: An immunohistochemical and pathological study of the changes of neoplastic phenotype. Oncol Lett 2014; 7: 1459-1463.
8.
Srivastava A, Lauwers GY. Gastric epithelial dysplasia: the Western perspective. Dig Liver Dis 2008; 40: 641-649.
9.
Yakirevich E, Resnick MB. Pathology of gastric cancer and its precursor lesions. Gastroenterol Clin North Am 2013; 42: 261-284.
10.
Spoelstra-de Man AM, Wagenaat SS, Van der Sluys Veer A, et al. Relationship between pernicious anaemia and gastric neuroendocrine cell disorders. Neth J Med 2000; 56: 56-62.
11.
Nasierowska-Guttmejer A. Neuroendocrine neoplasms of the stomach. Pol J Pathol 2013; 64: 40-46.
12.
Schlemper RJ, Riddell RH, Kato Y, et al. The Vienna classification of gastrointestinal epithelial neoplasia. Gut 2000; 47: 251-255.
13.
The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach and colon. Gastrointest Endosc 2003; 58 (6 Suppl): S3-S43.
14.
Bosman FT, Carneiro F, Hruban RH, Thiese ND (eds.). WHO Classifiication of Tumors of the Digestive System. IARC, Lyon 2010.
15.
Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal – type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 1965; 64: 31-49.
16.
Declich P, Arrigoni GS, Omazzi B, et al. Sporadic fundic gland polyps and proximal polyposis associated with gastric adenocarcinoma share a common antral G cell hyperplasia. Gut 2013; 62: 1088-1089.
17.
Mizuguchi Y, Takei K, Matsubayashi J, et al. Mucin phenotypes and macroscopic shape of multiple hyperplastic polyps together with two carcinomas in the stomach. Hepatogastroenterology 2012; 59: 659-663.
18.
Ubukata H, Katano M, Koniski S, et al. Multifocal gastric cancer with variety of histological findings coexisting with hyperplastic polyps: report of a case. Surg Today 2011; 41: 1106-1111.
19.
Carneiro F, David L, Seruca R, et al. Hyperplastic polyposis and diffuse carcinoma of the stomach. A study of family. Cancer 1993; 72: 323-329.
20.
Jang HW, Jeong HY, Kim SH, et al. Adenocarcinoma occurring in gastric hyperplastic polyp treated with endoscopic submucosal dissection. J Gastric Cancer 2013; 13: 117-120.
21.
Terada T. Malignant transformation of foveolar hyperplastic polyp of the stomach: a histopathological study. Med Oncol 2011; 28: 941-944.
22.
Dirschmid K, Platz-Baudin C, Stolte M. Why is the hyperplastic polyp a marker for precancerous condition of gastric mucoca. Virchow Arch 2006; 448: 80-84.
23.
Han AR, Sung CO, Kim KM, et al. The clinicopathological features of gastric hyperplastic polyps with neoplastic transformations: a suggestion of indication for endoscopic polypectomy. Gut Liver 2009; 3: 271-275.
24.
Silverman ML, Gibb P, Dai R, et al. The relationship of hyperplastic gastric polyps to carcinoid tumors. Am J Clin Pathol 1984; 82: 367.
25.
Chetty R, Gill P, Mugon P, et al. Gastric neuroendocrine cell hyperplasia and type 1 tumours occurring within gastric hyperplastic polyps. Virchows Arch 2012; 461: 483-487.
26.
Shimoda T, Tanoue S, Ikegami M, et al. A histopathological study of diffuse hyperplasia of gastric argyrophil cells. Acta Pathol Jpn 1983; 33: 1259-1267.
27.
Adhikari D, Conte Ch, Eskrais D, et al. Combined adenocarcinoma and carcinoid tumor in atrophic gastritis. Ann Clin Lab Sci 2002; 32: 422-427.
28.
Lahner E, Esposito G, Pilozzi E, et al. Gastric cancer in patients with type I gastric carcinoids. Gastric Cancer 2015; 18: 564-570.
29.
Wang LL, Yao GY, Zhao ZS, et al. Clonality analysis of neuroendocrine cells in gastric adenocarcinoma. World J Gastroenterol 2013; 28: 5340-5346.
30.
Bonar SF, Sweeney EC. The prevalence, prognostic significance and hormonal content of endocrine cells in gastric cancer. Histopathology 1985; 10: 53-63.
31.
Waldum HL, Brenna E, Sandvik AK. Relationship of ECL cells and gastric neoplasia. Yale J Biol Med 1998; 71: 325-335.